State of New Jersey Common Pension Fund D Has $2.32 Million Stake in Oscar Health, Inc. (NYSE:OSCR)

State of New Jersey Common Pension Fund D increased its stake in Oscar Health, Inc. (NYSE:OSCR) by 18.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 109,590 shares of the company’s stock after purchasing an additional 17,427 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Oscar Health were worth $2,324,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd acquired a new position in shares of Oscar Health during the second quarter worth about $78,000. Quest Partners LLC bought a new stake in Oscar Health in the 2nd quarter valued at approximately $93,000. Amalgamated Bank boosted its position in Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after acquiring an additional 1,458 shares during the last quarter. Optimum Investment Advisors bought a new position in shares of Oscar Health during the 3rd quarter worth approximately $142,000. Finally, Farallon Capital Management LLC acquired a new stake in shares of Oscar Health in the first quarter valued at approximately $164,000. Institutional investors own 75.70% of the company’s stock.

Insiders Place Their Bets

In related news, Vice Chairman Joshua Kushner acquired 276,040 shares of the company’s stock in a transaction dated Monday, November 11th. The shares were bought at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the completion of the transaction, the insider now directly owns 5,031,262 shares of the company’s stock, valued at $68,324,537.96. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, Vice Chairman Joshua Kushner purchased 276,040 shares of the stock in a transaction on Monday, November 11th. The shares were purchased at an average cost of $13.58 per share, with a total value of $3,748,623.20. Following the acquisition, the insider now directly owns 5,031,262 shares in the company, valued at $68,324,537.96. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the sale, the insider now owns 76,982 shares of the company’s stock, valued at approximately $1,384,906.18. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders purchased 1,055,478 shares of company stock valued at $14,432,852 and sold 169,569 shares valued at $3,007,069. Company insiders own 25.11% of the company’s stock.

Oscar Health Stock Performance

Oscar Health stock opened at $13.48 on Thursday. The stock has a 50-day simple moving average of $18.36 and a 200 day simple moving average of $18.33. The company has a current ratio of 0.73, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $6.93 and a 52 week high of $23.79.

Oscar Health (NYSE:OSCR) last issued its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The business had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter in the prior year, the firm posted ($0.29) earnings per share. The business’s revenue was up 68.3% compared to the same quarter last year. As a group, sell-side analysts forecast that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Analyst Ratings Changes

OSCR has been the subject of a number of analyst reports. UBS Group started coverage on shares of Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price for the company. Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Finally, Piper Sandler reissued an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a research report on Tuesday, September 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.